US20160310740A1 - Method for stimulating heart muscle activity during the refractory period - Google Patents

Method for stimulating heart muscle activity during the refractory period Download PDF

Info

Publication number
US20160310740A1
US20160310740A1 US14/695,237 US201514695237A US2016310740A1 US 20160310740 A1 US20160310740 A1 US 20160310740A1 US 201514695237 A US201514695237 A US 201514695237A US 2016310740 A1 US2016310740 A1 US 2016310740A1
Authority
US
United States
Prior art keywords
heart muscle
heart
recited
time
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/695,237
Inventor
Guy P. Curtis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guy P Curtis And Frances L Curtis Trust
Original Assignee
Guy P Curtis And Frances L Curtis Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guy P Curtis And Frances L Curtis Trust filed Critical Guy P Curtis And Frances L Curtis Trust
Priority to US14/695,237 priority Critical patent/US20160310740A1/en
Assigned to GUY P. CURTIS AND FRANCES L. CURTIS TRUST reassignment GUY P. CURTIS AND FRANCES L. CURTIS TRUST ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CURTIS, GUY P.
Priority to US14/815,711 priority patent/US20160310724A1/en
Priority to EP16783536.2A priority patent/EP3285853B1/en
Priority to PCT/US2016/018867 priority patent/WO2016171790A1/en
Priority to JP2017555459A priority patent/JP2018512971A/en
Publication of US20160310740A1 publication Critical patent/US20160310740A1/en
Priority to US16/653,538 priority patent/US11565113B2/en
Priority to JP2019004243U priority patent/JP3224852U/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36114Cardiac control, e.g. by vagal stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0587Epicardial electrode systems; Endocardial electrodes piercing the pericardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36507Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by gradient or slope of the heart potential

Definitions

  • the present invention pertains to systems and methods for improving heart muscle function. More particularly, the present invention pertains to systems and methods which stimulate sympathetic nerves to secrete norepinephrine during the absolute refractory period of a heart muscle cycle, to thereby improve heart muscle contraction.
  • the present invention is particularly, but not exclusively, useful as a system or method wherein nerve stimulation in the absolute refractory period is triggered by a local electrical depolarization of the heart muscle.
  • a normal heart muscle cycle i.e. a heartbeat
  • a heartbeat is repetitive and is characterized by several well-known and distinctly identifiable mechanical and electrical characteristics.
  • the heart muscle In its mechanical cycle, the heart muscle alternately functions to pump blood into the vasculature of a patient by its contractions (systole), and to receive blood from the vasculature by its relaxation (diastole).
  • the heart muscle cycle is the result of an electrical cycle that is superposed on the mechanical cycle. Of immediate interest here, however, is the absolute refractory period.
  • the heart muscle is not able to respond to an electrical stimulation.
  • Sympathetic nerves on the epicardial surface of the heart can be electrically stimulated during the absolute refractory period to thereby secrete norepinephrine.
  • the import here is that the secreted norepinephrine can then subsequently assist in controlling and improving a heart muscle contraction. It is, of course, essential to stimulate the sympathetic nerve during the heart's absolute refractory period so that the electrical and mechanical cycles of the heart are not disturbed.
  • Identifying the appropriate time for electrically stimulating a sympathetic nerve must necessarily be established relative to the heart muscle cycle.
  • the timing for nerve stimulation has been determined by the operation of a pacing device.
  • U.S. Pat. No. 8,463,376, which issued to Curtis for an invention entitled “System and Method for Transvascular Activation of Cardiac Nerves with Automatic Restart,” discloses and claims the electrically paced stimulation of a heart muscle.
  • the present invention now recognizes that the heart muscle itself creates natural signals (i.e. electrical events) which can be used to trigger a subsequent electrical stimulation of a sympathetic nerve. Importantly, this subsequent nerve stimulation can be timed to occur in the absolute refractory period of the heart muscle cycle.
  • an object of the present invention to provide a system and method for electrically stimulating a sympathetic nerve of a patient in response to a naturally occurring electrical event of the heart muscle. Another object of the present invention is to electrically stimulate a sympathetic nerve of a patient using a single pulse, or multiple pulses, during the absolute refractory period of a heart muscle cycle to assist with a contraction of the patient's heart muscle. Still another object of the present invention is to provide a system and method for electrically stimulating a sympathetic nerve of a patient which is easy to use, is simple to manufacture and is commercially cost effective.
  • a system and method are provided to improve the heart contractions of a patient during a heart function cycle (heartbeat).
  • a deployment catheter is used to position an electrode and a sensor in an epicardial vein that is located on the epicardial surface of the heart. A proper positioning of the electrode and the sensor requires they be located adjacent a sympathetic nerve.
  • the present invention detects a local electrical event (depolarization) of the heart muscle. Based on the occurrence of this local electrical event at a time t 0 , a stimulation interval, ⁇ t, is established.
  • ⁇ t begins at the time t 0 , and it ends at a time t 1 during the absolute refractory period of the heart function cycle.
  • the sympathetic nerve which is located on the epicardial surface of the heart, is stimulated. With this stimulation the sympathetic nerve will secrete norepinephrine to improve a subsequent contraction of the heart.
  • a device of the present invention includes a sensor for detecting the local electrical event of the heart, at the time t 0 .
  • a local electrical event is selected and used that occurs during a heart contraction, during diastole, in the patient's natural heart muscle cycle.
  • the device also includes a timer that is activated at the time t 0 and is used for measuring the predetermined stimulation interval ⁇ t.
  • the device includes a stimulator that is connected with an electrode for stimulating the sympathetic nerve with at least one electrical pulse at the time t 1 .
  • the electrical pulse(s) for stimulating the sympathetic nerve has(have) a predetermined intensity that is essentially less than about three times the intensity required for activating a contraction of the heart muscle.
  • the system of the present invention may also include a pacing device which, along with the sensor, can be selectively connected by a switch with the stimulator.
  • the pacing device when selected, is used to electronically establish t 0 .
  • the switch can be used to selectively alternate between a connection of the stimulator with the sensor, or with the pacing device, the overall purpose and functionality of the system remains unchanged.
  • Additional components for the device of the present invention include a voltage source that will generate the electrical pulse at the time t 1 .
  • These components also include a computer for coordinating an operation of the stimulator with respective operations of the sensor, the pacing device, the switch, and the timer.
  • a method for electrically stimulating a sympathetic nerve of a patient to improve heart function requires first positioning an electrode/sensor in an epicardial vein, on the epicardial surface of the heart, adjacent the sympathetic nerve. The electrode/sensor is then used to detect a local electrical event. Specifically, the local electrical event that is to be detected by the sensor needs to occur near the electrode and will result from the patient's natural heart muscle cycle.
  • a computer can then be used to establish a predetermined stimulation interval ⁇ t that will extend from the start time t 0 , to a time t 1 .
  • the computer can then activate the stimulator at the time t 1 .
  • the purpose here is to electrically stimulate the sympathetic nerve with at least one electrical pulse, to thereby improve a subsequent contraction of the patient's heart muscle.
  • an operation of the present invention requires consecutively repeating the stimulation interval ⁇ t for each heart function cycle.
  • the stimulation interval ⁇ t that determines when a sympathetic nerve is to be stimulated is in an approximate range of 100-120 msec.
  • the electrical pulse(s) for stimulating the sympathetic nerve has(have) a predetermined intensity that is less than about three times the intensity required for activating a contraction of the heart muscle.
  • FIG. 1 is a depiction of a system in accordance with the present invention shown together with the intended environment of its operation;
  • FIG. 2 is a functional layout of the components employed in a system of the present invention
  • FIG. 3 is a time-line depiction of a heart muscle cycle with an operation of the present invention superposed thereon in its relation to the absolute refractory period;
  • FIG. 4 is a logic flow chart for the functional tasks that are required during an operation of the computer-controlled system of the present invention.
  • a system for electrically stimulating a sympathetic nerve of a patient to improve heart function is shown and is generally designated 10 .
  • the system 10 includes a deployment catheter 12 which has a sensor 14 and an electrode 16 that are mounted in combination at the distal end of the deployment catheter 12 .
  • the system 10 also includes various electronic components which are disclosed below with reference to FIG. 2 . As disclosed below, these electronic components are mounted in the console 18 and interact with each other to provide operational control over the system 10 .
  • the console 18 may be either extracorporeal or implantable.
  • the console 18 may be part of a pacemaker or a defibrillator.
  • a heart muscle 20 is shown as the surgical target for the present invention.
  • Anatomically, a view of the diaphragmatic surface of the heart muscle 20 shows its coronary sinus 22 and several connecting veins.
  • the posterior vein 24 of the left ventricle, and the middle cardiac vein 26 are shown.
  • sympathetic nerve(s) 28 in the nervous system of which the nerve bundles 28 a, 28 b and 28 c are only exemplary.
  • the nerves 28 are located on the epicardial surface of the left ventricle, and they are adjacent to either the coronary sinus 22 or one of the veins connected with the coronary sinus 22 (e.g. veins 24 or 26 ).
  • a computer 30 is provided for the system 10 , and that the computer 30 is electronically connected with a switch 32 , a timer 34 , a stimulator 36 and a voltage source 38 .
  • a pacing device 40 can also be electronically incorporated with the aforementioned components.
  • the switch 32 , the timer 34 , the stimulator 36 , and the voltage source 38 , as well as the pacing device 40 can all be mounted on the extracorporeal console 18 .
  • the sensor 14 and the electrode 16 are incorporated into the deployment catheter 12 .
  • FIG. 2 For a disclosure of their interaction with each other, the components mentioned above are shown in FIG. 2 in their relationship with the heart muscle 20 .
  • the sensor 14 and the electrode 16 are operationally shown in direct contact with the heart muscle 20 .
  • the switch 32 is used to alternatively connect the sensor 14 or the pacing device 40 with the timer 34 .
  • the stimulator 36 is energized by the voltage source 38 for a timed activation of the electrode 16 .
  • the electrode 16 will stimulate a sympathetic nerve 28 on the heart muscle 20 .
  • each pulse that is used to stimulate the sympathetic nerve 28 will have an intensity that is less than about three times the intensity required for activating a contraction of the heart muscle 20 .
  • FIG. 3 The depiction of a normal heart function cycle (i.e. a heartbeat) is shown in FIG. 3 and is generally designated 42 .
  • the heart function cycle 42 is depicted by an isoelectric line 44 .
  • the absolute refractory period 46 of the heart function cycle 42 is shown in its overall relationship with the heart function cycle 42 .
  • the absolute refractory period 46 is a period of time in which the heart muscle 20 is not able to respond to an electrical stimulation.
  • the present invention requires there be a stimulation of a sympathetic nerve 28 during the absolute refractory period 46 .
  • the system 10 of the present invention establishes a stimulation interval 48 that will begin with an electrical event 50 at a time t 0 and will end at a time t 1 in the absolute refractory period 46 when a sympathetic nerve 28 is stimulated.
  • an exemplary electrical event 50 is shown on the isoelectric line 44 to occur at a time t 0 .
  • the exact time for selection of an occurrence for the electrical event 50 is somewhat arbitrary. Preferably, however, it will be before and relatively near the beginning of the absolute refractory period 46 .
  • a pacing device 40 can be employed to set the start time t 0 .
  • ⁇ t will be in an approximate range of 100 to 120 msec. Again, note with reference to FIG. 3 that the time t 1 falls within the absolute refractory period 46 .
  • FIG. 4 A logic flow chart for the tasks to be performed during an operation of the present invention is shown in FIG. 4 and is generally designated 52 .
  • the inquiry block 54 questions whether the sensor 14 is being used. If so, task block 56 requires that the heart muscle function be monitored by the sensor 14 .
  • inquiry block 58 asks whether an electrical event 50 has been detected. If not, the sensor 14 continues monitoring the heart function cycle 42 . On the other hand, if an electrical event 50 is detected, task block 60 requires the establishment of a stimulation interval 48 .
  • the stimulation interval ⁇ t 48 extends from a time t 0 when the electrical event 50 is detected, to a time t 1 when a pulse(s) is(are) to be fired by the stimulator 36 to stimulate a sympathetic nerve 28 .
  • a pacing device 40 rather than the sensor 14 , is used to trigger the stimulation interval 48 .
  • inquiry block 54 together with task block 62 directs there be an engagement of the timer 34 with the pacing device 40 .
  • the inquiry block 64 and task block 66 together, indicate that when the stimulation interval 48 has expired, the stimulator 36 is activated by the computer 30 to stimulate the sympathetic nerve 28 .
  • the system 10 then proceeds to monitor the next heart function cycle 42 .

Abstract

A system and method for improving heart contractions during a heart function cycle (heartbeat) of a patient requires detecting a local electrical event (depolarization) during the cycle. This local electrical event is then used to trigger a stimulation interval Δt at a time t0. Importantly, the stimulation interval Δt is set to end at a time t1 during the absolute refractory period of the heart function cycle. At the time t1, a stimulator is triggered to stimulate a local sympathetic nerve on the epicardial surface of the heart. With this stimulation the sympathetic nerve secretes norepinephrine to improve a subsequent contraction of the heart.

Description

    FIELD OF THE INVENTION
  • The present invention pertains to systems and methods for improving heart muscle function. More particularly, the present invention pertains to systems and methods which stimulate sympathetic nerves to secrete norepinephrine during the absolute refractory period of a heart muscle cycle, to thereby improve heart muscle contraction. The present invention is particularly, but not exclusively, useful as a system or method wherein nerve stimulation in the absolute refractory period is triggered by a local electrical depolarization of the heart muscle.
  • BACKGROUND OF THE INVENTION
  • A normal heart muscle cycle (i.e. a heartbeat) is repetitive and is characterized by several well-known and distinctly identifiable mechanical and electrical characteristics. In its mechanical cycle, the heart muscle alternately functions to pump blood into the vasculature of a patient by its contractions (systole), and to receive blood from the vasculature by its relaxation (diastole). Physiologically, the heart muscle cycle is the result of an electrical cycle that is superposed on the mechanical cycle. Of immediate interest here, however, is the absolute refractory period.
  • During the absolute refractory period, which follows cell firing during diastole, and which is approximately 120-300 msec in duration, the heart muscle is not able to respond to an electrical stimulation. Sympathetic nerves on the epicardial surface of the heart, however, can be electrically stimulated during the absolute refractory period to thereby secrete norepinephrine. The import here is that the secreted norepinephrine can then subsequently assist in controlling and improving a heart muscle contraction. It is, of course, essential to stimulate the sympathetic nerve during the heart's absolute refractory period so that the electrical and mechanical cycles of the heart are not disturbed.
  • Identifying the appropriate time for electrically stimulating a sympathetic nerve must necessarily be established relative to the heart muscle cycle. Heretofore, the timing for nerve stimulation has been determined by the operation of a pacing device. For example, U.S. Pat. No. 8,463,376, which issued to Curtis for an invention entitled “System and Method for Transvascular Activation of Cardiac Nerves with Automatic Restart,” discloses and claims the electrically paced stimulation of a heart muscle.
  • The present invention now recognizes that the heart muscle itself creates natural signals (i.e. electrical events) which can be used to trigger a subsequent electrical stimulation of a sympathetic nerve. Importantly, this subsequent nerve stimulation can be timed to occur in the absolute refractory period of the heart muscle cycle.
  • With the above in mind, it is an object of the present invention to provide a system and method for electrically stimulating a sympathetic nerve of a patient in response to a naturally occurring electrical event of the heart muscle. Another object of the present invention is to electrically stimulate a sympathetic nerve of a patient using a single pulse, or multiple pulses, during the absolute refractory period of a heart muscle cycle to assist with a contraction of the patient's heart muscle. Still another object of the present invention is to provide a system and method for electrically stimulating a sympathetic nerve of a patient which is easy to use, is simple to manufacture and is commercially cost effective.
  • SUMMARY OF THE INVENTION
  • In accordance with the present invention, a system and method are provided to improve the heart contractions of a patient during a heart function cycle (heartbeat). To set up the system for its operation, a deployment catheter is used to position an electrode and a sensor in an epicardial vein that is located on the epicardial surface of the heart. A proper positioning of the electrode and the sensor requires they be located adjacent a sympathetic nerve.
  • In an overview of the present invention, it is to be appreciated that, during each heart function cycle, the present invention detects a local electrical event (depolarization) of the heart muscle. Based on the occurrence of this local electrical event at a time t0, a stimulation interval, Δt, is established. In detail, Δt begins at the time t0, and it ends at a time t1 during the absolute refractory period of the heart function cycle. At the time t1, the sympathetic nerve, which is located on the epicardial surface of the heart, is stimulated. With this stimulation the sympathetic nerve will secrete norepinephrine to improve a subsequent contraction of the heart.
  • Structurally, a device of the present invention includes a sensor for detecting the local electrical event of the heart, at the time t0. Typically, a local electrical event is selected and used that occurs during a heart contraction, during diastole, in the patient's natural heart muscle cycle. The device also includes a timer that is activated at the time t0 and is used for measuring the predetermined stimulation interval Δt. Recall, Δt extends between the start time t0 and the time t1 in the absolute refractory period of the patient's heart cycle (Δt=t1−t0). Further, the device includes a stimulator that is connected with an electrode for stimulating the sympathetic nerve with at least one electrical pulse at the time t1. Preferably, the electrical pulse(s) for stimulating the sympathetic nerve has(have) a predetermined intensity that is essentially less than about three times the intensity required for activating a contraction of the heart muscle.
  • For an alternate embodiment of the present invention, the system of the present invention may also include a pacing device which, along with the sensor, can be selectively connected by a switch with the stimulator. For this embodiment, when selected, the pacing device is used to electronically establish t0. Although the switch can be used to selectively alternate between a connection of the stimulator with the sensor, or with the pacing device, the overall purpose and functionality of the system remains unchanged.
  • Additional components for the device of the present invention include a voltage source that will generate the electrical pulse at the time t1. These components also include a computer for coordinating an operation of the stimulator with respective operations of the sensor, the pacing device, the switch, and the timer.
  • From a functional perspective, the methodology of the present invention is dependent on the heart function cycle. Accordingly, a method for electrically stimulating a sympathetic nerve of a patient to improve heart function requires first positioning an electrode/sensor in an epicardial vein, on the epicardial surface of the heart, adjacent the sympathetic nerve. The electrode/sensor is then used to detect a local electrical event. Specifically, the local electrical event that is to be detected by the sensor needs to occur near the electrode and will result from the patient's natural heart muscle cycle.
  • Once a local electrical event is detected, a computer can then be used to establish a predetermined stimulation interval Δt that will extend from the start time t0, to a time t1. As noted above, the time t1 needs to fall in the absolute refractory period of the patient's natural heart muscle cycle (t1−t0=Δt). The computer can then activate the stimulator at the time t1. The purpose here, of course, is to electrically stimulate the sympathetic nerve with at least one electrical pulse, to thereby improve a subsequent contraction of the patient's heart muscle.
  • With the above in mind, it is to be understood that an operation of the present invention requires consecutively repeating the stimulation interval Δt for each heart function cycle. Also, the stimulation interval Δt that determines when a sympathetic nerve is to be stimulated is in an approximate range of 100-120 msec. Further, the electrical pulse(s) for stimulating the sympathetic nerve has(have) a predetermined intensity that is less than about three times the intensity required for activating a contraction of the heart muscle.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The novel features of this invention, as well as the invention itself, both as to its structure and its operation, will be best understood from the accompanying drawings, taken in conjunction with the accompanying description, in which similar reference characters refer to similar parts, and in which:
  • FIG. 1 is a depiction of a system in accordance with the present invention shown together with the intended environment of its operation;
  • FIG. 2 is a functional layout of the components employed in a system of the present invention;
  • FIG. 3 is a time-line depiction of a heart muscle cycle with an operation of the present invention superposed thereon in its relation to the absolute refractory period; and
  • FIG. 4 is a logic flow chart for the functional tasks that are required during an operation of the computer-controlled system of the present invention.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Referring initially to FIG. 1, a system for electrically stimulating a sympathetic nerve of a patient to improve heart function is shown and is generally designated 10. As shown, the system 10 includes a deployment catheter 12 which has a sensor 14 and an electrode 16 that are mounted in combination at the distal end of the deployment catheter 12. In addition to the mechanical components mentioned above, the system 10 also includes various electronic components which are disclosed below with reference to FIG. 2. As disclosed below, these electronic components are mounted in the console 18 and interact with each other to provide operational control over the system 10. For purposes of the present invention, it is to be appreciated that the console 18 may be either extracorporeal or implantable. For example, as an implantable, the console 18 may be part of a pacemaker or a defibrillator.
  • Still referring to FIG. 1, a heart muscle 20 is shown as the surgical target for the present invention. Anatomically, a view of the diaphragmatic surface of the heart muscle 20 shows its coronary sinus 22 and several connecting veins. In particular, the posterior vein 24 of the left ventricle, and the middle cardiac vein 26 are shown. Also shown are sympathetic nerve(s) 28 in the nervous system, of which the nerve bundles 28 a, 28 b and 28 c are only exemplary. Importantly, the nerves 28 are located on the epicardial surface of the left ventricle, and they are adjacent to either the coronary sinus 22 or one of the veins connected with the coronary sinus 22 (e.g. veins 24 or 26).
  • Referring now to FIG. 2, it will be seen that a computer 30 is provided for the system 10, and that the computer 30 is electronically connected with a switch 32, a timer 34, a stimulator 36 and a voltage source 38. Optionally, a pacing device 40 can also be electronically incorporated with the aforementioned components. As will be best appreciated by cross-reference between FIG. 1 and FIG. 2, the switch 32, the timer 34, the stimulator 36, and the voltage source 38, as well as the pacing device 40, can all be mounted on the extracorporeal console 18. On the other hand, as disclosed above, the sensor 14 and the electrode 16 are incorporated into the deployment catheter 12.
  • For a disclosure of their interaction with each other, the components mentioned above are shown in FIG. 2 in their relationship with the heart muscle 20. Specifically, the sensor 14 and the electrode 16 are operationally shown in direct contact with the heart muscle 20. Depending on whether the operation of system 10 is to rely on a paced event, which can be alternatively provided using the pacing device 40, the switch 32 is used to alternatively connect the sensor 14 or the pacing device 40 with the timer 34. Further, under the control of the computer 30, the stimulator 36 is energized by the voltage source 38 for a timed activation of the electrode 16. In turn, the electrode 16 will stimulate a sympathetic nerve 28 on the heart muscle 20. As envisioned for the present invention, each pulse that is used to stimulate the sympathetic nerve 28 will have an intensity that is less than about three times the intensity required for activating a contraction of the heart muscle 20.
  • The depiction of a normal heart function cycle (i.e. a heartbeat) is shown in FIG. 3 and is generally designated 42. As shown, the heart function cycle 42 is depicted by an isoelectric line 44. In this context, the absolute refractory period 46 of the heart function cycle 42 is shown in its overall relationship with the heart function cycle 42. As discussed above, the absolute refractory period 46 is a period of time in which the heart muscle 20 is not able to respond to an electrical stimulation. As also discussed above, the present invention requires there be a stimulation of a sympathetic nerve 28 during the absolute refractory period 46. To do this, the system 10 of the present invention establishes a stimulation interval 48 that will begin with an electrical event 50 at a time t0 and will end at a time t1 in the absolute refractory period 46 when a sympathetic nerve 28 is stimulated.
  • Still referring to FIG. 3 an exemplary electrical event 50 is shown on the isoelectric line 44 to occur at a time t0. As envisioned by the present invention, the exact time for selection of an occurrence for the electrical event 50 is somewhat arbitrary. Preferably, however, it will be before and relatively near the beginning of the absolute refractory period 46. As indicated above, in an alternate embodiment of the present invention a pacing device 40 can be employed to set the start time t0. In any event, once a time t0 has been determined for the electrical event 50, or set by the pacing device 40, the stimulation interval 48 can be established. Mathematically expressed, t1−t0=Δt, wherein Δt is the stimulation interval 48. Preferably, Δt will be in an approximate range of 100 to 120 msec. Again, note with reference to FIG. 3 that the time t1 falls within the absolute refractory period 46.
  • A logic flow chart for the tasks to be performed during an operation of the present invention is shown in FIG. 4 and is generally designated 52. After the start of an operation, the inquiry block 54 questions whether the sensor 14 is being used. If so, task block 56 requires that the heart muscle function be monitored by the sensor 14. Next, inquiry block 58 asks whether an electrical event 50 has been detected. If not, the sensor 14 continues monitoring the heart function cycle 42. On the other hand, if an electrical event 50 is detected, task block 60 requires the establishment of a stimulation interval 48. As disclosed above, the stimulation interval Δt 48 extends from a time t0 when the electrical event 50 is detected, to a time t1 when a pulse(s) is(are) to be fired by the stimulator 36 to stimulate a sympathetic nerve 28. Recall, in an alternate embodiment of the present invention, a pacing device 40, rather than the sensor 14, is used to trigger the stimulation interval 48. Thus, for the alternate embodiment, inquiry block 54 together with task block 62 directs there be an engagement of the timer 34 with the pacing device 40. In all embodiments, however, the inquiry block 64 and task block 66, together, indicate that when the stimulation interval 48 has expired, the stimulator 36 is activated by the computer 30 to stimulate the sympathetic nerve 28. The system 10 then proceeds to monitor the next heart function cycle 42.
  • While the particular Method for Stimulating Heart Muscle Activity During the Refractory Period as herein shown and disclosed in detail is fully capable of obtaining the objects and providing the advantages herein before stated, it is to be understood that it is merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended to the details of construction or design herein shown other than as described in the appended claims.

Claims (20)

What is claimed is:
1. A method for electrically stimulating a sympathetic nerve of a patient to improve heart function, the method comprising the steps of:
positioning an electrode in an epicardial vein, on the epicardial surface of the heart adjacent the sympathetic nerve;
detecting a local electrical event with the electrode/sensor, wherein the local electrical event occurs near the electrode/sensor and results from the patient's natural heart muscle cycle;
using the detected local electrical event to trigger a start time t0;
waiting a predetermined time interval Δt after the start time t0, until a time t1, wherein t1 is in the absolute refractory period of the patient's natural heart muscle cycle (t1−t0=Δt); and
activating a stimulator at the time t1 to electrically stimulate the sympathetic nerve with at least one electrical pulse to improve contractions of the patient's heart muscle.
2. The method as recited in claim 1 wherein Δt constitutes a stimulation interval, and the method further comprises the step of consecutively repeating the stimulation interval.
3. The method as recited in claim 1 further comprising the steps of:
deferring the detecting step and the using step; and
implementing a pacing device to trigger the start time t0.
4. The method as recited in claim 1 wherein Δt is in a range of 100-120 msec.
5. The method as recited in claim 1 wherein the electrical pulse for stimulating the sympathetic nerve has a predetermined intensity less than three times the intensity required for activating a contraction of the heart muscle.
6. The method as recited in claim 1 wherein the start time t0 is triggered by a local electrical event in the patient's heart muscle during a contraction of the heart muscle.
7. The method as recited in claim 1 wherein the start time t0 is triggered by an electrical event in the patient's heart muscle during diastole of the heart muscle.
8. A device for electrically stimulating a sympathetic nerve of a patient to improve heart function which comprises:
a sensor for detecting an electrical event of the heart at a time t0 during the patient's natural heart muscle cycle;
a timer for measuring a stimulation interval having a predetermined time interval Δt between the start time t0 and a time t1, wherein t1 is in the absolute refractory period of the patient's heart cycle (Δt=t1−t0); and
a stimulator connected with an electrode for stimulating the sympathetic nerve with at least one electrical pulse at the time t1, to improve a contraction of the heart muscle.
9. The device as recited in claim 8 further comprising a deployment catheter for positioning the electrode in an epicardial vein, on the epicardial surface of the heart adjacent the sympathetic nerve.
10. The device as recited in claim 8 further comprising:
a pacing device selectively connected with the stimulator to electronically establish t0; and
a switch to selectively alternate between a connection of the stimulator with the sensor and with the pacing device.
11. The device as recited in claim 10 further comprising:
a voltage source to generate the electrical pulse at the time t1; and
a computer for coordinating an operation of the stimulator with respective operations of the sensor, the pacing device, the switch, and the timer.
12. The device as recited in claim 8 wherein the electrical pulse for stimulating the sympathetic nerve has a predetermined intensity less than three times the intensity required for activating a contraction of the heart muscle.
13. The device as recited in claim 8 wherein Δt constitutes a stimulation cycle, and the stimulation interval is continuously repeated.
14. The device as recited in claim 8 wherein the stimulation interval Δt is in a range of 100-120 msec.
15. The device as recited in claim 8 wherein the start time t0 is triggered by an electrical event in the patient's heart muscle during a contraction of the heart muscle.
16. The device as recited in claim 8 wherein the start time t0 is triggered by an electrical event in the patient's heart muscle during diastole of the heart muscle.
17. A non-transitory, computer readable medium having executable instructions stored thereon that direct a computer system to perform a process which comprises: detecting an electrical event of the heart at a time t0 during the patient's natural heart muscle cycle; measuring a stimulation interval having a predetermined time interval Δt between the start time t0 and a time t1 wherein t1 is in the absolute refractory period of the patient's heart cycle (Δt=t1−t0); and stimulating the sympathetic nerve with at least one electrical pulse at the time t1 to improve a contraction of the heart muscle, wherein the electrical pulse has a predetermined intensity less than three times the intensity required for activating a contraction of the heart muscle.
18. The non-transitory, computer-readable medium as recited in claim 17 further comprising instructions for: selectively alternating between a connection and a disconnection of a sensor for detecting the electrical event, with a stimulator for stimulating the sympathetic nerve; and using a pacing device for establishing t0 when the sensor is disconnected from the stimulator.
19. The non-transitory, computer-readable medium as recited in claim 18 wherein Δt constitutes a stimulation interval, and the stimulation interval is continuously repeated for successive heart muscle cycles, and further wherein the stimulation interval Δt is in a range of 100-120 msec.
20. The non-transitory, computer-readable medium as recited in claim 18 wherein the start time t0 is triggered by an electrical event in the patient's heart muscle during a time period including contraction and diastole.
US14/695,237 2015-04-24 2015-04-24 Method for stimulating heart muscle activity during the refractory period Abandoned US20160310740A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US14/695,237 US20160310740A1 (en) 2015-04-24 2015-04-24 Method for stimulating heart muscle activity during the refractory period
US14/815,711 US20160310724A1 (en) 2015-04-24 2015-07-31 System and method for electrode placement in the pericardial sac of a patient
EP16783536.2A EP3285853B1 (en) 2015-04-24 2016-02-22 Device for stimulating heart muscle activity during the refractory period
PCT/US2016/018867 WO2016171790A1 (en) 2015-04-24 2016-02-22 Method for stimulating heart muscle activity during the refractory period
JP2017555459A JP2018512971A (en) 2015-04-24 2016-02-22 Method for stimulating myocardial activity during the refractory period
US16/653,538 US11565113B2 (en) 2015-04-24 2019-10-15 Method for stimulating heart muscle activity during the refractory period
JP2019004243U JP3224852U (en) 2015-04-24 2019-11-08 Methods for stimulating myocardial activity during the refractory period

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/695,237 US20160310740A1 (en) 2015-04-24 2015-04-24 Method for stimulating heart muscle activity during the refractory period

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/815,711 Continuation-In-Part US20160310724A1 (en) 2015-04-24 2015-07-31 System and method for electrode placement in the pericardial sac of a patient
US16/653,538 Division US11565113B2 (en) 2015-04-24 2019-10-15 Method for stimulating heart muscle activity during the refractory period

Publications (1)

Publication Number Publication Date
US20160310740A1 true US20160310740A1 (en) 2016-10-27

Family

ID=57143350

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/695,237 Abandoned US20160310740A1 (en) 2015-04-24 2015-04-24 Method for stimulating heart muscle activity during the refractory period
US16/653,538 Active 2036-05-08 US11565113B2 (en) 2015-04-24 2019-10-15 Method for stimulating heart muscle activity during the refractory period

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/653,538 Active 2036-05-08 US11565113B2 (en) 2015-04-24 2019-10-15 Method for stimulating heart muscle activity during the refractory period

Country Status (4)

Country Link
US (2) US20160310740A1 (en)
EP (1) EP3285853B1 (en)
JP (2) JP2018512971A (en)
WO (1) WO2016171790A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11167145B2 (en) 2019-10-30 2021-11-09 Guy P. Curtis And Frances L. Curtis Trust System and method for indirect measurement of ventricular contractility

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040199210A1 (en) * 2002-06-12 2004-10-07 Shelchuk Anne M. Vagal stimulation for improving cardiac function in heart failure or CHF patients
US20080132966A1 (en) * 2006-12-05 2008-06-05 G&L Consulting, Llc Stimulation of coronary artery baroreceptors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4252830B2 (en) * 2003-03-24 2009-04-08 テルモ株式会社 Heart treatment equipment
US7233824B2 (en) * 2003-10-07 2007-06-19 Medtronic, Inc. Secure and efficacious therapy delivery for an extra-systolic stimulation pacing engine
US7570999B2 (en) * 2005-12-20 2009-08-04 Cardiac Pacemakers, Inc. Implantable device for treating epilepsy and cardiac rhythm disorders
CA2653110C (en) * 2006-03-29 2018-07-31 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US8478406B2 (en) * 2006-04-24 2013-07-02 Medtronic, Inc. Apparatus and methods of delivering an enhanced refractory period stimulation therapy
US20080269819A1 (en) * 2007-04-26 2008-10-30 Xiaohong Zhou Discrimination of supraventricular tachycardia from ventricular tachycardia
US8463376B2 (en) 2008-08-12 2013-06-11 Guy P. Curtis System and method for transvascular activation of cardiac nerves with automatic restart
JP2011103981A (en) * 2009-11-13 2011-06-02 Olympus Corp Nerve stimulation device
US8504158B2 (en) * 2011-05-09 2013-08-06 Medtronic, Inc. Phrenic nerve stimulation during cardiac refractory period
JP6001059B2 (en) * 2011-06-07 2016-10-05 ザ ガイ ピー.カーティス アンド フランセス エル.カーティス トラスト System and method for transvascular activation of cardiac nerve with automatic restart function
JP5846816B2 (en) * 2011-09-15 2016-01-20 オリンパス株式会社 Nerve stimulator

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040199210A1 (en) * 2002-06-12 2004-10-07 Shelchuk Anne M. Vagal stimulation for improving cardiac function in heart failure or CHF patients
US20080132966A1 (en) * 2006-12-05 2008-06-05 G&L Consulting, Llc Stimulation of coronary artery baroreceptors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11167145B2 (en) 2019-10-30 2021-11-09 Guy P. Curtis And Frances L. Curtis Trust System and method for indirect measurement of ventricular contractility

Also Published As

Publication number Publication date
JP2018512971A (en) 2018-05-24
EP3285853A4 (en) 2018-09-05
WO2016171790A1 (en) 2016-10-27
JP3224852U (en) 2020-01-23
US11565113B2 (en) 2023-01-31
WO2016171790A8 (en) 2017-01-19
EP3285853A1 (en) 2018-02-28
US20200038661A1 (en) 2020-02-06
EP3285853B1 (en) 2021-07-28
US20200398056A9 (en) 2020-12-24

Similar Documents

Publication Publication Date Title
EP2558160B1 (en) Autonomic modulation using transient response with intermittent neural stimulation
EP0727241B1 (en) Device for heart stimulation
US9168382B2 (en) Method and apparatus for selective his bundle pacing
US8209013B2 (en) Therapeutic electrical stimulation that avoids undesirable activation
EP2153867A2 (en) System and method for transvascular activation of cardiac nerves to improve heart function
EP1486232A2 (en) Device for improving cardiac funtion in heart failure or CHF patients
KR102630590B1 (en) Methods and systems for treating cardiac dysfunction
JP4629673B2 (en) Electrically effective neural excitatory stimulation
JP2014533578A (en) Management of cross therapy sensing in implantable devices for multiple therapy
US11565113B2 (en) Method for stimulating heart muscle activity during the refractory period
US7321794B2 (en) Method and system for treating atrial fibrillation
US8214033B2 (en) Interferential cardiac preconditioning and depolarization
US10744327B2 (en) Active electrical nerve stimulation medical device, with automatic charge compensation control
US11389656B2 (en) Active implantable medical device for nerve stimulation therapy with dynamic adjustment of stimulation periods
US8463376B2 (en) System and method for transvascular activation of cardiac nerves with automatic restart
EP2717962B1 (en) System for transvascular activation of cardiac nerves with automatic restart
US20160310724A1 (en) System and method for electrode placement in the pericardial sac of a patient
US20230173281A1 (en) Hypertension his bundle pacing
WO2017023382A1 (en) System and method for electrode placement in the pericardial sac of a patient
JP2005013504A (en) Heart treatment device
US8744558B2 (en) Method and apparatus for providing ipselateral therapy
EP4126201A1 (en) Cardiac contractility modulation in association with respiration

Legal Events

Date Code Title Description
AS Assignment

Owner name: GUY P. CURTIS AND FRANCES L. CURTIS TRUST, CALIFOR

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CURTIS, GUY P.;REEL/FRAME:035855/0254

Effective date: 20150603

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION